Publications (51 results)
Please use discretion when following external links; Assaypro cannot guarantee the validity and security of all citation links provided.Galectin-3 as a Marker for Increased Thrombogenicity in COVID-19
- https://www.mdpi.com/1422-0067/24/9/7683
- M Puccini, K Jakobs, L Reinshagen, J Friebel… - International Journal of …, 2023 - mdpi.com
- Galectin-3 is a beta-galactoside-binding lectin involved in inflammation and lung fibrosis and postulated to enhance thrombosis. In COVID-19, it is considered to be a prognostic marker …
Association of galectin-3 and coagulation parameters in hospitalized patients with COVID-19
- https://refubium.fu-berlin.de/handle/fub188/49389
- M Puccini Dicolloredo Mels - 2025 - refubium.fu-berlin.de
- From the beginning of the coronavirus disease 19 (COVID-19) pandemic, it was observed that diseased patients displayed a higher thrombogenic risk. Multiple studies were performed …
Association of galectin-3 and coagulation parameters in hospi-talized patients with COVID-19 Zusammenhang zwischen Galectin-3 und …
* Polaska P et al. (2023) Coagulation abnormalities as predictors of renal dysfunction in heart failure with reduced ejection fraction. Medical Studies.39 (2): 148-158.
* Sabouni R et al. (2021) Drospirenone effects on the plasminogen activator system in immortalized human endometrial endothelial cells. Reprod Sci. 28(7):1974-1980.
* Ravi GK et al. (2021) Effect of tranexamic acid on blood loss, coagulation profile, and quality of surgical field in intracranial meningioma resection: A prospective randomized, double-blind, placebo-controlled study. Surg Neurol Int. 12:272.
* Nakano T et al. (2021) Arsenite Inhibits Tissue-Type Plasminogen Activator Synthesis through NRF2 Activation in Cultured Human Vascular Endothelial EA.hy926 Cells. Int J Mol Sci. 22(2):739.
* Nagelkirk PR et al.(2021) Regular Resistance Training Enhances Fibrinolytic Potential but Does Not Affect Coagulation. Med Sci Sports Exerc. 53(11):2318-2323.
* Maguire D et al. (2021) Post-traumatic stress disorder: A biopsychosocial case-control study investigating peripheral blood protein biomarkers. Biomarkers in Neuropshchiatry 5:100042.
* Hara T et al. (2021) Cadmium induces plasminogen activator inhibitor-1 via Smad2/3 signaling pathway in human endothelial EA. hy926 cells. J.Toxicol.Sci. 46(5):249-253.
* Tahtamouni LH et al. (2020) Alu-repeat polymorphism in the tissue plasminogen activator (t-PA) gene, seminal t-PA concentration, and male fertility impairment: A case-control study. Int J Reprod Biomed. 18(8):571-578.
* Sackett JR et al. (2020) Hemostatic Adaptations to High Intensity Interval Training in Healthy Adult Men. Int J Sports Med. 41(12):867-872.
* Schmitt FCF et al. (2019) Acute fbrinolysis shutdown occurs early in septic shock and is associated with increased morbidity and mortality: results of an observational pilot study. Ann. Intensive Care. 9:19.
* Siennicka A et al. (2018) Homocysteine-Enhanced Proteolytic and Fibrinolytic Processes in Thin Intraluminal Thrombus and Adjacent Wall of Abdominal Aortic Aneurysm: Study In Vitro. Biomed Res Int. 2018: 3205324.
* Siennicka A et al. (2018) Tissue factor levels and the fibrinolytic system in thin and thick intraluminal thrombus and underlying walls of abdominal aortic aneurysms. Journal of Vascular Surgery.
* Rhone P (2018) Comprehensive analysis of haemostatic profile depending on clinicopathological determinants in breast cancer patients. Biosci Rep. 29;38(2)
* Imoto Y et al. (2018) Short chain fatty acids induce tissue plasminogen activator in airway epithelial cells via GPR 41&43. Clin Exp Allergy. 48(5): 544-554.
* Sun W et al. (2017) A combined therapy of rtPA-loaded thermoresponsive gels and ultrasound on hematoma in a rat model of intracerebral hemorrhage. RSC Adv. 7:15809-15816.
* Bystricky B et al. (2017) Relationship between circulating tumor cells and tissue plasminogen activator in patients with early breast cancer. Anticance Res. 37(4): 1787-1791.
* Zhou Y et al. (2016) Intervention of chlorogenic acid, caffeic acid and ferulic acid on the expression of inflammation-related molecules in endothelial cells caused by complement bypass activation. Chi.Pharma. Bulletin. 32(12): 1723-1728.
* Lee JM (2016) Hemostatic markers and long-term risk of intracerebral hemorrhage in postmenopausal women. J Stroke Cerebrovasc Dis. 25(7): 1639-1643.
* Halim SA et al. (2015) Simultaneous Consideration of Multiple Candidate Protein Biomarkers for Long-Term Risk for Cardiovascular Events. Circ Cardiovasc Genet. 8(1):168-77
* Topcuoglu A et al. (2014) Effects of hormone replacement therapy on plasma and tissue fibrinolytic activity in a rat model of surgically induced menopause. Clin Invest Med. 2014 Apr 1;37(2):E85-92
* Akkok B et al. (2014) Pleural effusion and plasma levels of fibrinolytic parameters in tuberculosis pleurisy and contribution to the diagnosis. Eurasian J Pulmonol. 16: 84-88
* Akkok B et al. (2014) Pleural effusion and plasma levels of fibrinolytic parameters in tuberculosis pleurisy and contribution to the diagnosis. Eurasian J Pulmonol. 16: 84-88
* Vieira ML et al. (2013) Interaction of Leptospira interrogans with Human Proteolytic Systems Enhances Dissemination through Endothelial Cells and Protease Levels. Infect Immun. 81(5):1764-74. doi: 10.1128/IAI.00020-13. Epub 2013 Mar 11
* Takabayashi T et al. (2013) Excessive fibrin deposition in nasal polyps caused by fibrinolytic impairment through reduction of tissue plasminogen activator expression. Am J Respir Crit Care Med. 187(1):49-57.
* Siennicka A et al. (2013) Haemostatic factors and intraluminal thrombus thickness in abdominal aortic aneurysm. Is secondary fibrinolysis relevant? J Physiol Pharmacol. 64(3):321-30
* Nsimba MM et al. (2013) Effect of a Congolese herbal medicine used in sickle cell anemia on the expression of plasminogen activators in human coronary aortic endothelial cells culture. J Ethnopharmacol. 146(2):594-9
* Ekwere T et al. (2013) Assessment of some plasma fibrinolytic proteins in sickle cell anemia patients in steady state and in vaso-occlusive crises. Journal of Applied Hematology. 4(4):131-136
* Baumer W et al. (2013) Pharmacokinetics and thrombolytic effects of the recombinant tissue-type plasminogen activator in horses. BMC Veterinary Research 9:158
* Zhu H et al. (2012) Activation of coagulation, anti-coagulation, fibrinolysis and the complement system in patients with urticaria. Asian Pac J Allergy Immunol 31:43-50
* Zhou Y et al. (2012) The high-level expression of human tissue plasminogen activator in the milk of transgenic mice with hybrid gene locus strategy. Mol Biotechnol. 50(2):137-44.
* Vieira ML et al. (2012) The interaction of Leptospira interrogans with juman proteolytic system enhaces dissemination through endothelial cells and the levels of plasminogen activators and matrix metalloprotease-9. University of Sao Paulo.
* Qi J et al. (2012) A novel fibrinogenase from Agkistrodon acutus venom protects against DIC via direct degradation of thrombosis and activation of protein C. Biochem Pharmacol. 84(7):905-13.
* Maruyama K et al. (2012) Plasma levels of platelet-derived microparticles are increased after anaerobic exercise in healthy subjects. J Atheroscler Thromb. 19 (6):585-587
* Tuttolomondo A et al. (2010) Immune-inflammatory markers and arterial stiffness indexes in subjects with acute ischemic stroke. Atherosclerosis. 213(1):311-8.
* Turfaner N et al. (2010) Ezetimibe Therapy and Its Influence on Oxidative Stress and Fibrinolytic Activity. South Med J. 103:428-433
* Suzuki N et al. (2010) GnRH receptor and peritoneal plasmin activity. Gynecol Endocrinol. 26(9):669-672
* Suzuki N and Imai A (2010) HMG-CoA reductase inhibitor lovastatin upregulates plasminogen activator production through RhoA-signaling in peritoneal cell line Met5A. Gynecol Surg. 7:189-193.
* Munuswamy-Ramanujam G et al. (2010) Neuroserpin, a thrombolytic serine protease inhibitor (serpin), blocks transplant vasculopathy with associated modification of T-helper cell subsets. Thromb Haemost. 103(3):545-555
* Kesavan K et al. (2010) Annexin A2 Is a Molecular Target for TM601, a Peptide with Tumor-targeting and Anti-angiogenic Effects. J Biol Chem. 285(7):4366-4374
* Tabak O et al. (2009) Hypertension and hemostatic/fibrinolytic balance disorders. Clin Invest Med. 32(6):E285
* Markosyan N and Duffy DM (2009) Prostaglandin E2 acts via multiple receptors to regulate plasminogen-dependent proteolysis in the primate periovulatory follicle. Endocrinology. 150(1):435-44
* He WJ et al. (2008) Activated protein C ratio, plasma tissue factor activity and activated factor VII in Chinese patients with coronary heart disease. Eur J Med Res. 13:47-51
* Demirel A et al. (2008) Is Familial Mediterranean Fever a thrombotic disease or not? Eur J Pediatr. 167(3):279-285
* Katsutani M et al. (2007) Glucose-Based PD Solution, But Not Icodextrin-Based PD Solution, Induces Plasminogen Activator Inhibitor-1 and Tissue-Type Plasminogen Activator in Human Peritoneal Mesothelial Cells via ERK1/2. Ther Apher Dial. 11(2): 94-100.
* Nagai T et al. (2006) The rewards of nicotine: regulation by tissue plasminogen activator-plasmin system through protease activated receptor-1. The Journal of Neuroscience 26(47):12374-12383
* Sheikh AM et al. (2005) Lysophosphatidylcholine induces tPA gene expression through CRE-dependent mechanism. Biochem Biophys Res Commun. 329(1):71-77
* Mataga N et al. (2004) Experience-Dependent Pruning of Dendritic Spines in Visual Cortex by Tissue Plasminogen Activator. Neuron 44:1031-1041
